Highlights d FANCD2 regulates CFS replication even in the absence of replicative stress d Replication forks stall at endogenous CFS loci in FANCD2 patient-derived cells d DNA:RNA hybrid removal restores normal replication at CFS-FRA16D d FANCD2 deficiency is associated with altered replication initiation SUMMARY Common fragile sites (CFSs) are genomic regions that are unstable under conditions of replicative stress.
In Brief
Cells lacking proteins associated with the Fanconi anemia pathway are prone to chromosome breaks at CFSs. Madireddy et al. show that FANCD2 facilitates replication through repeat-rich genomic regions such as CFSs by ameliorating DNA:RNA hybrid accumulation and by influencing dormant origin firing, even during unperturbed replication.
INTRODUCTION
Nearly two-thirds of the human genome is composed of repetitive sequences that often challenge DNA replication, which can lead to genomic instability. Common fragile sites (CFSs) are chromosomal regions that are most prone to genomic instability and are implicated in the development and progression of cancer (Arlt et al., 2003; Glover, 2006) . Furthermore, CFSs are hot spots for chromosomal structural aberrations such as deletions, duplications, and translocations (Chesi et al., 1998; Finnis et al., 2005; O'Keefe and Richards, 2006) . Maintenance of CFS integrity is critical because most of the commonly expressed CFSs contain tumor suppressor genes and proto-oncogenes, which when altered are associated with a large spectrum of cancers (Ciullo et al., 2002; Hellman et al., 2002; Siprashvili et al., 1997) . The three most prevalent models of CFS instability involve the presence of structure-prone repetitive DNA sequences, the possibility of transcription-associated obstacles, and the scarcity of replication initiation events (Le Beau et al., 1998; Lucas et al., 2007) . Currently, it is believed that perturbed replication of these regions is at the heart of their fragility. Identifying the factors that alleviate replication perturbation at CFSs is vital to understanding the mechanism(s) leading to CFS instability.
Among the various proteins that have been implicated in CFS breakage are the Fanconi anemia (FA) proteins. FA is a genetic disorder characterized by developmental abnormalities, bone marrow failure, and a high incidence of malignancies. Although the repair-mediated functions of the FA pathway provide some mechanistic insight, the severe phenotypes observed in some FA patients (Hirsch et al., 2004; Howlett et al., 2002) and FA mouse models (Houghtaling et al., 2003) suggest additional roles for these proteins. Recent reports suggest a role for the FA pathway in DNA replication. The FA pathway is strongly activated in response to replisome stalling that occurs in response to agents that induce replicative stress, such as hydroxyurea (HU) (Petermann et al., 2010; Taniguchi et al., 2002) . Furthermore, FANCD2 transiently interacts with the MCM proteins (Lossaint et al., 2013) and stabilizes stalled replication forks (Karanja et al., 2014; Schlacher et al., 2012) .
In addition to increased risk for cancer (Kutler et al., 2003; Rosenberg et al., 2003) , the absence of FA proteins is associated with elevated chromosomal breaks at CFSs (Howlett et al., 2005) . The observed but unexplained exacerbation of CFS instability in the absence of FA proteins combined with the inherent replication defects found at CFSs prompted us to determine whether replication-associated functions of FA proteins also facilitate CFS replication. If the FA proteins are indeed mediating timely replication of CFSs, then their absence should challenge replication and result in the alteration of the replication program at CFS loci.
Here, we show that the FANCD2 protein is an important transacting mediator of CFS replication. By visualizing the in vivo replication dynamics of individual DNA fibers, we found a striking change in the replication program at the CFS loci in FANCD2 À/À patient-derived lymphoblasts. We propose that FANCD2 has a multifaceted role in facilitating replication at difficult to replicate genomic regions such as CFS. It helps the replication machinery navigate past the fragility core of CFS-FRA16D, likely by resolving impediments to replication machinery such as DNA:RNA hybrids. In this manner, FANCD2 appears to maintain CFS stability in the absence of exogenous stress and seems to do so independently from the rest of the FA core complex proteins and FANCD2 monoubiquitination. Additionally, FANCD2 also ensures optimal firing of dormant rescue origins to facilitate replication completion at CFSs to avoid mitotic instability. These studies provide key mechanistic insight into the role of FANCD2 in maintaining CFS stability and preserving genome integrity.
RESULTS

CFS-FRA16D Replication Program Is Altered in the Absence of FANCD2
We started our analysis with FANCD2-deficient cell lines because FANCD2 can facilitate DNA replication under conditions of replicative stress (Lossaint et al., 2013) . Using singlemolecule analysis of replicated DNA (SMARD) (Figure S1A, available online), we examined the endogenous replication program of two CFS loci, FRA16D and FRA6E. Lymphocytes were used because CFSs are usually mapped in lymphocytes (Sutherland and Richards, 1995) , and FRA16D and FRA6E are highly expressed in this cell type (Helmrich et al., 2011) . To analyze the movement of replication forks through the AT-rich fragility core of CFS-FRA16D, we analyzed a 280 kb PmeI segment of FRA16D that contained a portion of the AT-rich fragility core on the left and flanking DNA sequences on the right; this region is henceforth referred to as repeat region 1 (RR1) (Figures 1A and 1B; Table S1 ).
In non-affected lymphoblasts, GM02184 (non-affected 1) and GM03798 (non-affected 2), replication proceeds unperturbed, bidirectionally across the repeats, with equal numbers of 3 0 -to-5 0 and 5 0 -to-3 0 progressing forks replicating the locus (Figures 1C and S2B) . In contrast, in the FANCD2 À/À lymphoblasts (FANCD2 À/À -L-1 [PD20], FANCD2 À/À -L-2 [2742], and FANCD2 À/À -L-3 [2717]), the direction of replication was altered and replication forks progressed predominantly in the 3 0 -to-5 0 direction, into the fragility core, in $70% of the cells. Very few 5 0 -to-3 0 progressing replication forks managed to reach RR1 at the same time as the 3 0 -to-5 0 progressing forks (Figures 1D, 1E, and S2C) . Complementation of the FANCD2 À/À -L-1 lymphoblasts with wild-type FANCD2 protein ( Figure S3B ) restores bidirectional replication program at RR1 ( Figure 1F ), similar to the non-affected cells.
One possible explanation for the inability of the forks progressing in the 5 0 -to-3 0 direction to reach RR1 could be that the forks were stalled at the fragility core ( Figure 1A , pink line) of CFS-FRA16D, not included in RR1. To study the progression of the replication forks progressing 5 0 to 3 0 into RR1, we studied an adjacent segment, to the left of RR1, called repeat region 2 (RR2) ( Figures 1A and 2A ). Analysis of the replication program of RR2 in non-affected cells revealed that replication proceeds bidirectionally across the repeats in RR2 ( Figure 2B ). The FANCD2 À/À lymphoblasts also had a bidirectional replication program; however, there appeared to be an accumulation of replication forks at different regions along the 120 kb segment (Figures 2C and 2D) . Analysis of regions RR1+RR2 collectively revealed that the replication program at the AT-rich fragility core of CFS-FRA16D is altered in the absence of the FANCD2 protein.
In the Absence of FANCD2, Replication Forks Stall at the Fragility Core of CFSs Replication fork pausing can occur at regions of the genome that act as natural impediments to the DNA replication machinery (Mirkin and Mirkin, 2007) . To determine whether the altered replication program, at RR1, observed in the absence of FANCD2 is a result of replication pausing, we decided to quantify the replication pause sites at the endogenous fragility core of CFS-FRA16D. To do this, we divided the AT-rich fragility core of CFS-FRA16D (RR1+RR2), collectively spanning a 400 kb region, into 10 kb intervals. We then counted the number of 3 0 -to-5 0 or 5 0to-3 0 progressing replication forks that were present at each 10 kb interval at the time of replication. Figure S1B is a schematic representation of how replication pausing is quantified.
In the FANCD2 À/À lymphoblasts, the replication forks moving into RR1 (3 0 to 5 0 ; purple bars) ( Figure 2E , FANCD2 À/À -L-1 and FANCD2 À/À -L-2; Figure S3A , FANCD2 À/À -L-3) show increased pausing at the fragility core. In addition, replication forks moving in the 5 0 -to-3 0 direction appear to pause significantly upon entering the AT-rich core, in RR2 ( Figure 2E , FANCD2 À/À -L-1 and FANCD2 À/À -L-2, orange bars), indicating that FANCD2 is important for replisome movement across the AT-rich regions of CFS-FRA16D.
To further validate the hypothesis that the absence of FANCD2 results in replication fork pausing at CFSs, we quantified replication pausing at the fragility core of a second CFS, FRA6E. We Table S1 , providing additional information about fosmids and primers used to identify the regions. (B) Locus map of RR1-PmeI segment containing a portion of the AT-rich fragility core. The segments are aligned according to the positions of the fluorescence in situ hybridization (FISH) probes (blue) on the map. (C-F) Top: locus map of PmeI-digested RR1 segment. Middle: aligned photomicrographic images of labeled DNA molecules from (C) non-affected 1 (GM02184), (D) FANCD2 À/À -L-1 (PD20), (E) FANCD2 À/À -L-2 (2742), and (F) FANCD2 À/À -L-1 + FANCD2 (corrected) lymphoblast. The yellow arrows indicate the sites along the molecules where the IdU transitioned to CldU. The molecules are arranged in the following order: molecules with initiation events, molecules with 3 0 -to-5 0 progressing forks, molecules with 5 0 -to-3 0 progressing forks, and molecules with termination events. White ovals indicate regions of replication fork pausing and correspond to the pausing peaks listed in Table S2 . Bottom: the percentage of molecules incorporating IdU (red) is calculated from the replication program (middle) and is represented as a histogram.
analyzed a 375 kb region that includes the early/late replication transition zone that corresponds to the fragility core of FRA6E (Palumbo et al., 2010) ( Figure S4A ). The SMARD results show increased replication fork pausing, preferentially within the FRA6E fragility core, in FANCD2 À/À -L-1 cells ( Figure S4D ), indicating that FANCD2 is needed for proper replication at CFSs. Together, these results demonstrate that in the absence of FANCD2, the replication machinery finds it difficult to navigate the structure-prone fragility core of CFSs, even in the absence of exogenous replicative stress.
In the Absence of FANCD2, Dormant Replication Origins Are Activated at CFSs Replication fork stalling or slowing can be accompanied by the activation of dormant origins (Alver et al., 2014; Blow and Ge, 2009 ). In the absence of FANCD2, increased replication pausing was seen for the forks progressing in the 5 0 -to-3 0 direction into the fragility core of both CFS-FRA16D and CFS-FRA6E ( Figures  2E and S4D ). This raises the possibility of identifying dormant origins downstream of the pause site, which might have fired to compensate for the replication stalling. Therefore, we examined the replication program of a segment flanking RR1 of FRA16D, to the right, region 3 (R3) ( Figures 1A and 3A) .
Analysis of the non-affected cells revealed that only 2 of the 73 molecules displayed initiation events in the 305 kb R3 segment ( Figures 3B and S2D ). In comparison, all three FANCD2 À/À lymphoblasts activated a prominent dormant origin in more than a third of the R3 molecules ( Figures 3C, 3D , and S2E). Moreover, when FANCD2 protein expression was restored in the FANCD2 À/À -1 patient cells ( Figure S3B ), the dormant origin activation response was suppressed in the R3 segment ( Figure 3E ). Importantly, the appearance of this origin in the FANCD2-deficient cells supports the idea that pausing of forks progressing 5 0 to 3 0 through RR1 is accompanied by the activation of dormant origins downstream of the pause site ( Figure 3F ). To further test this prediction, we analyzed the replication program of CFS-FRA6E for dormant origin activity. In non-affected lymphoblasts, we found very few initiation events occurring along the 375 kb region of CFS-FRA6E (1 of 40 molecules in Figures S4B and S4E , gray bar). In contrast, the FANCD2 À/À -1 lymphoblasts had a prominent dormant origin activated in $12% of the molecules ( Figures S4C and S4E , red bar), downstream of the replication pause site. The results were similar to those obtained for FRA16D, which strengthens the mechanism we propose.
Next, we determined whether the pausing observed in the 3 0to-5 0 progressing forks in FRA16D resulted in the activation of dormant origins upstream of the fragility core. Thus, we analyzed region 4, adjacent to RR2 (left of RR2 in Figure 1A ), in FANCD2 À/À lymphoblasts. However, we did not find any detectable dormant origin activation upstream of the repeats. Interestingly, we found some distinct replication pausing in the 5 0 -to-3 0 direction, within 20-40 kb of the repeats (Figures S3C and  S3D) . These results collectively indicate that in the absence of FANCD2, the activation of the origins in R3 appears to generate the replication forks (3 0 to 5 0 ) required to complete replication of RR1 in order to compensate for the 5 0 -to-3 0 replication stalling observed in the fragility core of CFS.
Replication Perturbation at CFS-FRA16D Is Specific to FANCD2-Deficient Lymphoblasts, Not Fibroblasts CFS instability arises as a consequence of incomplete replication that could result from the lack of replication initiation events at the locus (Letessier et al., 2011) . Accordingly, CFSs are known to be less fragile or unstable in fibroblasts that have an abundance of initiation events (Durkin and Glover, 2007; Le Tallec et al., 2011) . So we next asked whether the absence of FANCD2 perturbs replication at FRA16D in fibroblasts. Non-affected fibroblasts had an abundance of replication origins in both RR1 and R3 regions of FRA16D ( Figures 4A, 4B , and 4D), in contrast to the paucity of initiation events observed in the non-affected lymphoblasts. This delineates the inherent differences in CFS-FRA16D replication between lymphocytes and fibroblasts, under unperturbed conditions. Similarly, the replication of FRA16D in FANCD2-deficient fibroblasts (FANCD2 À/À -F-1) was distinctly different from that of FANCD2-deficient lymphoblasts (Figure 4C) . Despite having a bidirectional replication program, similar to non-affected fibroblasts ( Figure 4B ), the FANCD2-deficient fibroblasts had some replication pausing, likely because of the repetitive DNA sequences at FRA16D ( Figure 4G ).
In R3 of FANCD2-deficient fibroblasts, there was a decrease in replication origins ( Figure 4E ) compared with non-affected fibroblasts ( Figure 4D ). Importantly, FANCD2 À/À fibroblasts did not activate the strong dormant origin observed in FANCD2 À/À lymphoblasts ( Figure 3C ). Complementation of FANCD2 À/À fibroblasts with wild-type protein ( Figure S6B ) led to an increase in replication initiation events (9 in 40 examined) at CFS-FRA16D ( Figure S6A ), indicating that the ectopic expression of FANCD2 rescues the FANCD2-associated initiation defect. These results Table S2 . (E) Top: locus map of the RR1 + RR2 regions. The RR1 quantification was included here to enable the visualization of replication pausing along the complete length of the fragility core. Bottom: the percentage of molecules with replication forks at each 10 kb interval of RR2 (left, quantification of molecules shown in B-D) and RR1 (right, quantification of molecules shown in Figures 1B-1D ) in the non-affected I (GM02184) line, FANCD2 À/À -L-1 (PD20), and the FANCD2 À/À -L-2 (2742) lymphoblasts. The replication forks moving in the 3 0 -to-5 0 direction and the forks moving in the 5 0 -to-3 0 direction are denoted by purple < and orange > colors, respectively. A high percentage of molecules with replication forks in a particular 10 kb interval is indicative of fork pausing in that interval. Black arrows denote the most prominent pause peaks (P1-P6) and correspond to the white ovals in the SMARD profile. Refer to Table S2 for the coordinates of the 10 kb region corresponding to the pause peaks. Figure 3 . In the Absence of FANCD2, Cells Activate Dormant Origins Associated with Replication Stalling at the AT-Rich Fragility Core of CFS (A) Locus map of R3-SbfI segment that lies outside the AT-rich fragility core to the right. The FISH probes that identify the segment are labeled in blue. Combinations of two or three probes were used to identify the R3 segment.
(legend continued on next page) indicate that FANCD2 deficiency prominently alters CFS replication only in cell types that express CFS (lymphoblasts) and have a paucity of replication initiation events at CFS.
Replication Pausing at CFS-FRA16D in the Absence of FANCD2 Is Attributed to DNA:RNA Hybrids Fragility of CFS (and the cell type-specific nature of these breaks) has also been attributed to differential expression of genes underlying CFS loci (Helmrich et al., 2011) . In agreement with this hypothesis, we observed higher WWOX expression in lymphoblasts compared with fibroblasts ( Figures S6C-S6D ). Collision of transcription and replication machinery and DNA:RNA hybrid formation have been implicated in instability at CFS loci, which harbor long transcribed genes (García-Muse and Aguilera, 2016; Helmrich et al., 2013) . Recent reports suggest that the FA pathway plays a role in protecting cells from the deleterious effects of DNA:RNA hybrids (García-Rubio et al., Schwab et al., 2015) .
In order to determine whether the replication pausing observed in the absence of FANCD2 is due to DNA:RNA hybrid formation, we performed a DNA:RNA hybrid immunoprecipitation (DRIP) analysis at three sites (chosen based on DRIP-seq databases from Nadel et al., 2015) of CFS-FRA16D (Table S3 ). At all three sites analyzed, there was an accumulation of DNA:RNA hybrids, preferentially in the absence of FANCD2 (Figure 5A , red bars). Treatment with RNaseH1, which cleaves the RNA component of DNA:RNA hybrids, resulted in a marked reduction in the DNA:RNA hybrid signal obtained in FANCD2deficient cells ( Figure 5A ). These results demonstrate that DNA:RNA hybrids do indeed accumulate at CFS loci, in the absence of FANCD2.
If DNA:RNA hybrids are responsible for replication perturbation at CFS-FRA16D, then overexpressing RNaseH1 should eliminate the source of stalling. To test this, we generated nonaffected/control and FANCD2 À/À -L-1 lymphoblasts expressing either the control eGFP vector ( Figure 5B, lanes 1 and 3) or the eGFP-tagged RNaseH1 vector (lanes 2 and 4) . The RR1 segment, in the presence of RNaseH1 overexpression, was replicated by equal numbers of 5 0 -to-3 0 and 3 0 -to-5 0 progressing replication forks, in FANCD2 À/À lymphoblasts, with no significant replication pausing ( Figure 5D ). Importantly, the replication program of the RNaseH1 overexpressing FANCD2 À/À lymphoblasts closely resembled the replication program of both non-affected lymphoblasts (Figures 1C and S2B) and also the non-affected lymphoblasts overexpressing RNaseH1 (Figure 5C ). This clearly shows that eliminating DNA:RNA hybrids alleviates pausing and restores bidirectional replication fork movement across the fragility core of FRA16D.
If the overexpression of RNaseH1 truly alleviates replication pausing, it should suppress dormant origins that fire to rescue replication. Accordingly, FANCD2 À/À lymphoblasts overexpressing RNaseH1 do not activate the strong dormant origin that was observed in R3 of FRA16D in FANCD2-deficient cells and very closely resembled the replication program of nonaffected cells ( Figure 5F ). Furthermore, no change in the replication program was observed at the R3 region in non-affected and FANCD2 À/À lymphoblasts expressing GFP control ( Figures S7A  and S7B ). Elimination of the source of replication perturbation (DNA:RNA hybrids), appears to have suppressed the need for rescue (dormant origins). These results clearly demonstrate that replication pausing at CFS-FRA16D in the absence of FANCD2 is associated with DNA:RNA hybrids.
Absence of Downstream FA Proteins, and Not the FA Core Complex Proteins, Resembles FANCD2 Deficiency FANCD2's role in CFS-FRA16D replication could stem from its involvement in the FA/BRCA pathway. If this were the case, deficiency in other FA proteins would be predicted to have a similar effect on CFS-FRA16D replication as seen in the absence of FANCD2. Alternatively, FANCD2 could be functioning independently of the FA/BRCA pathway to facilitate CFS-FRA16D replication. To discriminate between these possibilities, we wanted to analyze the replication program of CFS-FRA16D in other FA patient-derived lymphoblastoid lines and in the absence of FANCD2/FANCI monoubiquitination. First, we measured the relative levels of FANCD2 protein expression and found that FANCD2 protein was not expressed in all three FANCD2 À/À cell lines ( Figure S5A ). FANCD2 monoubiquitination was absent in cells expressing FANCI-K523R (FANCI monoubÀ/À ) and FANCD2-K561R (FANCD2 monoubÀ/À ) ( Figures S3B and S5A) .
In the absence of the FA core complex protein FANCA, equal numbers of 5 0 -to-3 0 and 3 0 -to-5 0 progressing replication forks replicated the RR1 region of CFS-FRA16D ( Figure S5C ). This was associated with a decrease of $10% in dormant initiation events ( Figure 6F , green bar), compared with FANCD2-deficient lymphoblasts (red bars). However, in the absence of the downstream FA protein BRCA2/FANCD1, forks progressing predominantly in the 3 0 -to-5 0 direction replicated RR1 ( Figure S5E ), similar to FANCD2-deficient cells. However, both FANCA À/À and FANCD1 À/À lymphoblasts had some replication fork pausing at RR1 ( Figures S5F and S5G) .
Analysis of the FANCI monoubÀ/À and FANCD2 monoubÀ/À cells revealed that the RR1 region was replicated by forks progressing in both 3 0 -to-5 0 and the 5 0 -to-3 0 directions, in FANCI monoubÀ/À lymphoblasts ( Figure S5D) , in contrast to FANCD2-deficient cells. Furthermore, both FANCI monoubÀ/À and FANCD2 monoubÀ/À cell lines activated fewer numbers of dormant origins at R3 of CFS-FRA16D ( Figures 6C, 6D, and 6F) . In contrast to FANCD2deficient cells, only 10% of the FANCD2 monoubÀ/À cells activated origins in R3 of FRA16D ( Figure 6F, purple bar) . Furthermore, the replication program of the FANCD2 monoubÀ/À lymphoblasts at R3 ( Figure 6D ) is similar to non-affected lymphoblasts. This indicates that the monoubiquitination of FANCD2 is not essential to facilitate CFS replication under unperturbed conditions. Despite the replication pausing observed, the bidirectional replication fork movement at RR1 in FANCA À/À and FANCI monoubÀ/À lymphoblasts indicates that replication fork movement is only partly hindered in the absence of the FA core complex proteins and perhaps FANCI/FANCD2 monoubiquitination, under unperturbed conditions. The replication program in R3 further supports this idea. Interestingly, the severity of the absence of downstream FA proteins (BRCA2/FANCD1) closely resembles FANCD2 deficiency. This indeed fits nicely with the observation that FANCD2 and the downstream FA protein BRCA2/FANCD1 are involved in replication fork restart independent of the FA pathway (Raghunandan et al., 2015) . In summary, these results show that although other FA proteins play a role in replication at the FRA16D locus, this role is not exactly the same as FANCD2.
Replication Initiation Events Are Strongly Associated with CFS Fragility
To understand the implications of FANCD2-associated CFS replication perturbation on CFS fragility, we compared CFS-FRA16D fragility in FANCD2-deficient lymphoblasts and fibroblasts. Results indicated that spontaneous FRA16D breaks accumulate in FANCD2 À/À cells, even in the absence of exogenous replicative stress. Treatment with mild doses (0.2 mM) of the replication inhibitor aphidicolin (APH) resulted in an $5-fold increase in FRA16D breaks in FANCD2-deficient lymphoblasts ( Figure 7A ). In comparison, FANCD2-deficient fibroblasts (FANCD2 À/À -F-1) did not display spontaneous breaks at FRA16D ( Figure 7A ). However, treatment with APH resulted in a significant increase (20%) in FRA16D breaks in FANCD2 À/À -F-1 cells ( Figure 7A ). This is possibly due to the initiation defect observed in the R3 segment of the FANCD2 À/À -F-1 cells, as there is a strong correlation between the abundance of initiation events at CFS loci and fragility (Letessier et al., 2011) . Furthermore, the secondary structureprone sequences at FRA16D still obstruct replication forks and lead to pausing ( Figure 4G ), likely contributing to the fragility still observed in FANCD2-deficient fibroblasts ( Figure 7A ). Complementation of FANCD2-deficient fibroblasts with wildtype FANCD2 suppressed FRA16D breaks.
In summary, perturbed replication at CFS in the absence of FANCD2 is associated with increased CFS fragility. The relative abundance of origins in fibroblasts (Figure 4) is potentially one of the reasons why CFS-FRA16D is less fragile in fibroblasts, compared with lymphoblasts. These results highlight the importance of FANCD2 to CFS-FRA16D replication, specifically in lymphoblasts, where these sites are fragile even in the absence of exogenous stress.
FANCD2 Deficiency Is Associated with a Decrease in Replication Initiation Sites
Replication initiation events are strongly associated with CFS fragility. Despite the strong dormant origin activated to rescue replication, the FRA16D locus persistently breaks in lymphoblasts deficient for FANCD2. Furthermore, although FANCD2deficient fibroblasts display a relatively unperturbed replication program at FRA16D, they too are fragile under stress. To understand this better, we studied the effect of FANCD2 deficiency on replication initiation by enumerating the number of sites at which initiation events occur at FRA16D. Figures 7B and S6E illustrate the locus map of the RR1+R3 segments of CFS-FRA16D and summarize the observed locations of initiation events in all eight lymphoblastoid cell lines ( Figure 7B ) and fibroblast lines ( Figure S6E ).
FANCD2 deficiency is associated with initiation events at fewer sites of FRA16D ( Figures 7B and S6E, red arrows) . This alteration in replication initiation sites is consistent between lymphoblasts and fibroblasts, indicating that this FANCD2-associated replication defect likely occurs genomic wide. These results suggest that although the FA pathway proteins share some common functions in alleviating replication pausing at CFS-FRA16D, FANCD2 appears to have an additional role in replication initiation, leading to the pronounced alterations in replication program at CFSs, in FANCD2-deficient lymphoblasts.
DISCUSSION
Although it has been clearly established that stress-induced replication intermediates occur at CFS (Chan et al., 2009) , the replicative difficulties that lead to incomplete replication and the mechanisms that promote replication completion have been elusive. The present study provides mechanistic insight into the multifaceted role of FANCD2 in enabling efficient replication of structure-prone CFS loci, by alleviating transcription:replication-associated conflicts and by possibly ensuring efficient replication initiation.
Our results suggest a model in which FANCD2 and the other FA proteins act as facilitators of CFS replication, even under unperturbed conditions ( Figure 7C ). In the presence of a functional FA/BRCA pathway, forks that appear to have originated from initiation events outside the CFS loci mediate replication. Upon reaching the AT-rich fragility core, replication forks manage to efficiently replicate the region and ensure replication completion. In the absence of FANCD2, replication is perturbed at CFS even in the absence of exogenous replicative stress. This manifests as replication fork pausing at the fragility core of FRA16D, possibly at sites of DNA:RNA hybrid accumulation, accompanied by dormant origin activation. This defect is further exacerbated by the observed reduction in the potential sites of replication initiation in the FANCD2-deficient lymphoblasts. On the basis of these observations we propose that FANCD2 has two unique roles in facilitating CFS replication to prevent genomic instability: (1) facilitating the movement of replication forks across secondary structures such as DNA:RNA hybrids and (2) efficient replication initiation.
In this study, we provide in vivo evidence of replication pausing at endogenous CFS loci, in human FA patient-derived lymphoblasts. In vitro studies suggest that [AT] n or [AT/TA] n flexible sequences found at CFSs (Glover, 2006; Zhang and Freudenreich, 2007) pose a challenge to the replicative DNA polymerase d (Shah et al., 2010) and lead to polymerase pausing at CFS repeat sequences . This implies that additional polymerases and/or accessory proteins are required for proper replication of CFS sequences. Strong candidates for this role are the FA/BRCA proteins (Howlett et al., 2005) , helicases (Chaudhury et al., 2013; Kamath-Loeb et al., 2000; Pellicioli and Muzi-Falconi, 2013) , translesion polymerases (Bergoglio et al., 2013; Rey et al., 2009) , and nucleases (Ying et al., 2013) . It has been shown that FANCD2, in association with endonucleases and Bloom syndrome helicase, resolves intermediates resulting from incomplete CFS replication in G2/M . However, it is possible that FANCD2's role in preserving CFS stability begins earlier in the cell cycle, during CFS replication.
During repair, FANCD2 can recruit additional polymerases to sites of damage (Fu et al., 2013) . The numerous replication pause sites observed in the absence of FANCD2 imply that it may be involved in recruiting proteins that assist in replicating CFS regions by a similar mechanism. Bidirectional replication fork movement observed in FANCD2 monoubÀ/À and FANCI monoubÀ/À lymphoblasts indicates that the monoubiquitination of FANCD2 is perhaps not essential for its role in facilitating CFS replication under unperturbed conditions. However, under conditions of severe replication stress, monoubiquitination of FANCD2 may be necessary to recruit endonucleases (e.g., FAN1) (Lachaud et al., 2016) , to CFS loci because the monoubiquitination of FANCD2 is critical for FA/BRCA pathway activation (Garcia-Higuera et al., 2001; Rajendra et al., 2014) .
In addition to AT-associated secondary structures, transcription-associated obstacles at CFSs are a major cause of instability. DNA:RNA hybrids can lead to genomic instability by obstructing the progression of replication machinery or by making the cell more susceptible to genotoxic stress (Aguilera and García-Muse, 2012) . Our results not only demonstrate that DNA:RNA hybrids form at CFSs but also show that replication forks tend to stall because of DNA:RNA hybrid accumulation. Collectively, our data suggest that transcription-associated conflicts are a major source of replication perturbation at CFSs and suggest that FANCD2 is key to alleviating these conflicts at CFSs. Interestingly, BRCA2 also prevents DNA:RNA induced genetic instability (Bhatia et al., 2014) , which could explain the severity of replication perturbation at FRA16D in the absence of BRCA2.
FANCD2 Influences the Efficiency of Replication Initiation
Under conditions of replicative stress, FANCD2 plays an important role in suppressing dormant origin firing, and this function is independent of the monoubiquitination of FANCD2 (Chen et al., 2015) . It is possible that this role of FANCD2 is contributing to the increased dormant origin activation ( Figure 6F ; $40%) observed in the absence of FANCD2. However, FANCD2-deficient fibroblasts from the same patient show decreased origin firing at the same genomic locus ( Figure 4E ). Furthermore, similar to recent reports, the most prominent effect of an inability to monoubiquitinate FANCD2 was a decrease in dormant origin firing ( Figure 6D) (Panneerselvam et al., 2014) . These results imply that in the absence of FANCD2 monoubiquitination, the activation of the dormant origin in R3 is perhaps not required to rescue replication, under unperturbed conditions. Irrespective of cell type, all FANCD2-deficient cell lines appeared to activate origins at fewer regions at the CFS-FRA16D locus ( Figures 7B and S6E) . These results delineate a role for FANCD2 in efficient replication origin firing. Because changes in origin use can be attributed to changes in chromatin looping (Buongiorno-Nardelli et al., 1982; Courbet et al., 2008) , this role of FANCD2 is possibly associated with changes to chromatin looping and/or with the histone chaperone activity of FANCD2 (Sato et al., 2012) . 
FA, CFS Instability, and Cancer
The results of this study demonstrate that replication perturbation due to DNA:RNA hybrids and defective replication initiation collectively contribute to CFS instability. Importantly, we propose that FANCD2 is a central regulator that overcomes these threats to CFS replication. The replication-associated functions of FANCD2 are particularly important at CFS loci, which are hypersensitive to replicative stress (Yunis et al., 1987) . On the basis of our results, we propose that FANCD2 and other FA proteins protect CFS from endogenous sources of replicative stress and ensure efficient replication completion at CFS to preserve genome integrity. However, FANCD2 and the downstream FA proteins have a more prominent role in replication at CFSs compared with the FA core complex proteins. Given the implicated role of CFS instability in oncogenesis, our results provide vital mechanistic insights into the increased cancer risk of FA patients.
EXPERIMENTAL PROCEDURES
Cell Culture GM02184 (non-affected 1), GM03798 (non-affected 2), GM16756 (PD20-FANCD2 À/À -L-1), GM13022 (FANCA À/À -L), and GM13023 (FANCD1 À/À -L) Epstein-Barr virus-transformed lymphoblasts were obtained from Coriell Cell Repositories and were grown in RPMI 1640 medium supplemented with 15% fetal bovine serum (FBS). The 2741-FANCD2 À/À -L-2 and 2717-FANCD2 À/À -L-3 cell lines were obtained from the Fanconi Anemia Tissue and Cell Repository at The Rockefeller University. The FANCA À/À -L, FANCI monoubÀ/À -L, FANCD1 À/À -L, 2741-FANCD2 À/À -L-2, 2717-FANCD2 À/À -L-3, and FANCD2 À/À -L-1 lymphoblasts and the complemented cell line FANCD2 À/À+FANCD2 -L-2 lymphoblasts were grown in RPMI 1640 medium supplemented with 15% FBS v/v, 1% L-glutamine (Invitrogen), 1% penicillin/ streptomycin (Invitrogen), and 1 mg/mL puromycin. AG03204 (IMR90) SV40-transformed fibroblasts (Coriell Cell Repositories), PD20-F (FANCD2 À/À fibroblasts) and the completed cell line, FANCD2 À/À+FANCD2 fibroblasts were maintained in DMEM supplemented with 15% FBS, 1% L-glutamine (Invitrogen), 1% penicillin/streptomycin (Invitrogen), and 1 mg/mL puromycin. SMARD SMARD analysis was carried our using a procedure described previously (Madireddy et al., 2016; Norio and Schildkraut, 2001; Gerhardt et al., 2014) . Briefly, exponentially growing cells were cultured in media containing 30 mM 5-iodo-2 0 -deoxyuridine (IdU) at 37 C for 4 hr (Sigma-Aldrich). After 4 hr, the cells were centrifuged at 800 rpm for 5 min, and the media containing IdU was removed. The cells were then cultured in fresh RPMI medium containing 30 mM 5-chloro-2 0 -deoxyuridine (CIdU) (Sigma-Aldrich), and the cells were incubated for an additional 4 hr. After 4 hr, the cells were then collected by centrifugation, and they were resuspended at 3 3 10 7 cells per mL in PBS. The cells were then resuspended in an equal volume of molten 1% InCert agarose (Lonza Rockland) in PBS. DNA gel plugs were made by pipetting the cell-agarose mixture into a chilled plastic mold with 0.5 3 0.2 cm wells with a depth of 0.9 cm. The gel plugs were allowed to solidify on ice for 30 min. The cells in the plugs were lysed in buffer containing 1% n-lauroylsarcosine (Sigma-Aldrich), 0.5 M EDTA, and 20 mg/mL proteinase K. The gel plugs were incubated at 50 C for 3 days and were treated with fresh proteinase K at 20 mg/mL concentration (Roche Diagnostics) every 24 hr. The plugs were then rinsed in Tris-EDTA (TE) and subjected to phenylmethanesulfonyl fluoride (PMSF) (Sigma-Aldrich) treatment. To prepare the cells for restriction enzyme digestion, the plugs were washed with 10 mM MgCl 2 and 10 mM Tris-HCl (pH 8.0), and the genomic DNA in the gel plugs was digested with 80 units of PmeI (NE BioLabs) at 37 C overnight. The digested gel plugs were rinsed with TE and cast into a 0.7% SeaPlaque GTG agarose gel (Lonza Rockland) for size separation of DNA by pulse field gel electrophoresis. Gel slices from the appropriate positions in the pulsed-field electrophoresis gel were melted at 72 C for 20 min. The melted agarose was digested with GELase enzyme (Epicenter Biotechnologies; 1 unit per 50 mL of agarose suspension) by incubating the GE-Lase-DNA-agarose mixture at 45 C for 4 hr. The resulting DNA was pipetted along one side of a coverslip that had been placed on top of a 3-aminopropyltriethoxysilane (Sigma-Aldrich)-coated glass slide and allowed to enter by capillary action. The DNA was denatured with sodium hydroxide in ethanol and then fixed with glutaraldehyde.
The slides containing the DNA were hybridized overnight with biotinylated probes (represented as blue bars on the CFS-FRA16D locus map). The next day, the slides were rinsed in 2 3 SSC (1 3 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) 1% SDS and washed in 40% formamide solution containing 2 3 SSC at 45 C for 5 min and rinsed in 2 3 SSC-0.1% IGEPAL CA-630. Following several detergent rinses (four times in 4 3 SSC-0.1% IGEPAL CA-630), the slides were blocked with 1% BSA for at least 20 min and treated with avidin Alexa Fluor 350 (Invitrogen Molecular Probes) for 20 min. The slides were rinsed with PBS containing 0.03% IGEPAL CA-630, treated with biotinylated anti-avidin D (Vector Laboratories) for 20 min, and rinsed again. The slides were then treated with avidin Alexa Fluor 350 for 20 min and rinsed again, as in the previous step. The slides were incubated with the IdU antibody, a mouse anti-bromodeoxyuridine (anti-BrdU) (Becton Dickinson Immunocytometry Systems), the antibody specific for CldU, a monoclonal rat anti-BrdU (Accurate Chemical and Scientific) and biotinylated anti-avidin D for 1 hr. This was followed by incubation with avidin Alexa Fluor 350 and secondary antibodies, Alexa Fluor 568 goat anti-mouse IgG (H+L) (Invitrogen Molecular Probes), and Alexa Fluor 488 goat anti-rat IgG (H+L) (Invitrogen Molecular Probes) for 1 hr. The coverslips were mounted with ProLong gold antifade reagent (Invitrogen) after a final PBS/CA630 rinse. Fluorescence microscopy was carried out using a Zeiss fluorescence microscope to monitor the IdU/CIdU nucleoside incorporation.
DRIP DRIP was performed mainly as previously described , with a few differences. Five hundred thousand cells were collected, washed with PBS, resuspended in 1.6 mL of TE, and treated overnight with 41.5 mL of 20% SDS and 5 mL of proteinase K (Roche). DNA was extracted with phenol-chloroform. Precipitated DNA was spooled, washed with 70% EtOH, resuspended gently in TE, and digested overnight with 50 U of HindIII, EcoRI, BsrGI, XbaI, and SspI, and BSA. For the negative control, half of the (B) FANCA À/À -L, (C) FANCI monoubÀ/À -L, (D) FANCD2 monoubÀ/À -L, and (E) FANCD1 À/À -L patient-derived lymphoblast. The molecules are arranged as in Figure 1 . Bottom: the percentage of molecules incorporating IdU (red) is represented as a histogram. (F) Percentage of molecules with initiation sites in R3 of non-affected I (GM02184, gray bar), FANCD2 À/À -L (red bars), FANCA À/À -L (green bar), FANCI monoubÀ/À -L (blue bar), FANCD2 monoubÀ/À -L (purple bar), and FANCD1 À/À -L (orange bar) patient-derived lymphoblast. Error bars represent mean ± SD from two independent experiments (*p < 0.05). See also Figure S5 .
DNA was treated with 4 mL RNase H1 (Ginno et al., 2012 ) (NE BioLabs) overnight. Five micrograms of the digested DNA was bound to 10 mL of S9.6 antibody (1 mg/mL) in 500 mL binding buffer (10 mM NaPO 4 , 140 mM NaCl, 0.05% Triton X-100) overnight at 4 C. DNA-antibody complexes were immunoprecipitated using Dynabeads Protein A (Invitrogen) for 2 hr at 4 C and washed three times with binding buffer. DNA was eluted with 50 mM Tris (pH 8.0), 10 mM EDTA, and 0.5% SDS, treated for 45 min with 7 mL proteinase K at 55 C, and cleaned with NucleoSpin Gel and PCR Clean-up (Macherey-Nagel).
The enrichment for each qPCR of interest was normalized with respect to the corresponding ratios of the input. 
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